A Study to Assess the Relative Bioavailability of Process Variants of Selumetinib in Healthy Male Volunteers

Clinical trial NCT02322749 · COMPLETED

Trial details

NCT number: NCT02322749
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers Bioequivalence or Bioavailability Study

Start date: 2015-02-01
Primary completion: 2015-04-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.